Medical Care
Global Ovarian Cancer Molecular Diagnostics Market Research Report 2025
- Jul 08, 25
- ID: 347424
- Pages: 78
- Figures: 74
- Views: 1
The global market for Ovarian Cancer Molecular Diagnostics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
A molecular approach for diagnosing ovarian cancer
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Ovarian Cancer Molecular Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ovarian Cancer Molecular Diagnostics.
The Ovarian Cancer Molecular Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Ovarian Cancer Molecular Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ovarian Cancer Molecular Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Foundationmedicine
Tellgen
Sansure
Premed
Berryoncology
Helixgen
Annoroad
Topgen
Geneis
Segment by Type
PCR
FISH
DNA Sequencing
Gene Chip
Segment by Application
Clinical Diagnosis
Drug Screening
Research
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Ovarian Cancer Molecular Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
A molecular approach for diagnosing ovarian cancer
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Ovarian Cancer Molecular Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ovarian Cancer Molecular Diagnostics.
The Ovarian Cancer Molecular Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Ovarian Cancer Molecular Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ovarian Cancer Molecular Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Foundationmedicine
Tellgen
Sansure
Premed
Berryoncology
Helixgen
Annoroad
Topgen
Geneis
Segment by Type
PCR
FISH
DNA Sequencing
Gene Chip
Segment by Application
Clinical Diagnosis
Drug Screening
Research
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Ovarian Cancer Molecular Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ovarian Cancer Molecular Diagnostics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 PCR
1.2.3 FISH
1.2.4 DNA Sequencing
1.2.5 Gene Chip
1.3 Market by Application
1.3.1 Global Ovarian Cancer Molecular Diagnostics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Clinical Diagnosis
1.3.3 Drug Screening
1.3.4 Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Ovarian Cancer Molecular Diagnostics Market Perspective (2020-2031)
2.2 Global Ovarian Cancer Molecular Diagnostics Growth Trends by Region
2.2.1 Global Ovarian Cancer Molecular Diagnostics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Ovarian Cancer Molecular Diagnostics Historic Market Size by Region (2020-2025)
2.2.3 Ovarian Cancer Molecular Diagnostics Forecasted Market Size by Region (2026-2031)
2.3 Ovarian Cancer Molecular Diagnostics Market Dynamics
2.3.1 Ovarian Cancer Molecular Diagnostics Industry Trends
2.3.2 Ovarian Cancer Molecular Diagnostics Market Drivers
2.3.3 Ovarian Cancer Molecular Diagnostics Market Challenges
2.3.4 Ovarian Cancer Molecular Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Ovarian Cancer Molecular Diagnostics Players by Revenue
3.1.1 Global Top Ovarian Cancer Molecular Diagnostics Players by Revenue (2020-2025)
3.1.2 Global Ovarian Cancer Molecular Diagnostics Revenue Market Share by Players (2020-2025)
3.2 Global Ovarian Cancer Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Ovarian Cancer Molecular Diagnostics Revenue
3.4 Global Ovarian Cancer Molecular Diagnostics Market Concentration Ratio
3.4.1 Global Ovarian Cancer Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ovarian Cancer Molecular Diagnostics Revenue in 2024
3.5 Global Key Players of Ovarian Cancer Molecular Diagnostics Head office and Area Served
3.6 Global Key Players of Ovarian Cancer Molecular Diagnostics, Product and Application
3.7 Global Key Players of Ovarian Cancer Molecular Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Ovarian Cancer Molecular Diagnostics Breakdown Data by Type
4.1 Global Ovarian Cancer Molecular Diagnostics Historic Market Size by Type (2020-2025)
4.2 Global Ovarian Cancer Molecular Diagnostics Forecasted Market Size by Type (2026-2031)
5 Ovarian Cancer Molecular Diagnostics Breakdown Data by Application
5.1 Global Ovarian Cancer Molecular Diagnostics Historic Market Size by Application (2020-2025)
5.2 Global Ovarian Cancer Molecular Diagnostics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Ovarian Cancer Molecular Diagnostics Market Size (2020-2031)
6.2 North America Ovarian Cancer Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Ovarian Cancer Molecular Diagnostics Market Size by Country (2020-2025)
6.4 North America Ovarian Cancer Molecular Diagnostics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Ovarian Cancer Molecular Diagnostics Market Size (2020-2031)
7.2 Europe Ovarian Cancer Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Ovarian Cancer Molecular Diagnostics Market Size by Country (2020-2025)
7.4 Europe Ovarian Cancer Molecular Diagnostics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Ovarian Cancer Molecular Diagnostics Market Size (2020-2031)
8.2 Asia-Pacific Ovarian Cancer Molecular Diagnostics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Ovarian Cancer Molecular Diagnostics Market Size by Region (2020-2025)
8.4 Asia-Pacific Ovarian Cancer Molecular Diagnostics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Ovarian Cancer Molecular Diagnostics Market Size (2020-2031)
9.2 Latin America Ovarian Cancer Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Ovarian Cancer Molecular Diagnostics Market Size by Country (2020-2025)
9.4 Latin America Ovarian Cancer Molecular Diagnostics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Ovarian Cancer Molecular Diagnostics Market Size (2020-2031)
10.2 Middle East & Africa Ovarian Cancer Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Ovarian Cancer Molecular Diagnostics Market Size by Country (2020-2025)
10.4 Middle East & Africa Ovarian Cancer Molecular Diagnostics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Ovarian Cancer Molecular Diagnostics Introduction
11.1.4 Roche Revenue in Ovarian Cancer Molecular Diagnostics Business (2020-2025)
11.1.5 Roche Recent Development
11.2 Foundationmedicine
11.2.1 Foundationmedicine Company Details
11.2.2 Foundationmedicine Business Overview
11.2.3 Foundationmedicine Ovarian Cancer Molecular Diagnostics Introduction
11.2.4 Foundationmedicine Revenue in Ovarian Cancer Molecular Diagnostics Business (2020-2025)
11.2.5 Foundationmedicine Recent Development
11.3 Tellgen
11.3.1 Tellgen Company Details
11.3.2 Tellgen Business Overview
11.3.3 Tellgen Ovarian Cancer Molecular Diagnostics Introduction
11.3.4 Tellgen Revenue in Ovarian Cancer Molecular Diagnostics Business (2020-2025)
11.3.5 Tellgen Recent Development
11.4 Sansure
11.4.1 Sansure Company Details
11.4.2 Sansure Business Overview
11.4.3 Sansure Ovarian Cancer Molecular Diagnostics Introduction
11.4.4 Sansure Revenue in Ovarian Cancer Molecular Diagnostics Business (2020-2025)
11.4.5 Sansure Recent Development
11.5 Premed
11.5.1 Premed Company Details
11.5.2 Premed Business Overview
11.5.3 Premed Ovarian Cancer Molecular Diagnostics Introduction
11.5.4 Premed Revenue in Ovarian Cancer Molecular Diagnostics Business (2020-2025)
11.5.5 Premed Recent Development
11.6 Berryoncology
11.6.1 Berryoncology Company Details
11.6.2 Berryoncology Business Overview
11.6.3 Berryoncology Ovarian Cancer Molecular Diagnostics Introduction
11.6.4 Berryoncology Revenue in Ovarian Cancer Molecular Diagnostics Business (2020-2025)
11.6.5 Berryoncology Recent Development
11.7 Helixgen
11.7.1 Helixgen Company Details
11.7.2 Helixgen Business Overview
11.7.3 Helixgen Ovarian Cancer Molecular Diagnostics Introduction
11.7.4 Helixgen Revenue in Ovarian Cancer Molecular Diagnostics Business (2020-2025)
11.7.5 Helixgen Recent Development
11.8 Annoroad
11.8.1 Annoroad Company Details
11.8.2 Annoroad Business Overview
11.8.3 Annoroad Ovarian Cancer Molecular Diagnostics Introduction
11.8.4 Annoroad Revenue in Ovarian Cancer Molecular Diagnostics Business (2020-2025)
11.8.5 Annoroad Recent Development
11.9 Topgen
11.9.1 Topgen Company Details
11.9.2 Topgen Business Overview
11.9.3 Topgen Ovarian Cancer Molecular Diagnostics Introduction
11.9.4 Topgen Revenue in Ovarian Cancer Molecular Diagnostics Business (2020-2025)
11.9.5 Topgen Recent Development
11.10 Geneis
11.10.1 Geneis Company Details
11.10.2 Geneis Business Overview
11.10.3 Geneis Ovarian Cancer Molecular Diagnostics Introduction
11.10.4 Geneis Revenue in Ovarian Cancer Molecular Diagnostics Business (2020-2025)
11.10.5 Geneis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ovarian Cancer Molecular Diagnostics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 PCR
1.2.3 FISH
1.2.4 DNA Sequencing
1.2.5 Gene Chip
1.3 Market by Application
1.3.1 Global Ovarian Cancer Molecular Diagnostics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Clinical Diagnosis
1.3.3 Drug Screening
1.3.4 Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Ovarian Cancer Molecular Diagnostics Market Perspective (2020-2031)
2.2 Global Ovarian Cancer Molecular Diagnostics Growth Trends by Region
2.2.1 Global Ovarian Cancer Molecular Diagnostics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Ovarian Cancer Molecular Diagnostics Historic Market Size by Region (2020-2025)
2.2.3 Ovarian Cancer Molecular Diagnostics Forecasted Market Size by Region (2026-2031)
2.3 Ovarian Cancer Molecular Diagnostics Market Dynamics
2.3.1 Ovarian Cancer Molecular Diagnostics Industry Trends
2.3.2 Ovarian Cancer Molecular Diagnostics Market Drivers
2.3.3 Ovarian Cancer Molecular Diagnostics Market Challenges
2.3.4 Ovarian Cancer Molecular Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Ovarian Cancer Molecular Diagnostics Players by Revenue
3.1.1 Global Top Ovarian Cancer Molecular Diagnostics Players by Revenue (2020-2025)
3.1.2 Global Ovarian Cancer Molecular Diagnostics Revenue Market Share by Players (2020-2025)
3.2 Global Ovarian Cancer Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Ovarian Cancer Molecular Diagnostics Revenue
3.4 Global Ovarian Cancer Molecular Diagnostics Market Concentration Ratio
3.4.1 Global Ovarian Cancer Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ovarian Cancer Molecular Diagnostics Revenue in 2024
3.5 Global Key Players of Ovarian Cancer Molecular Diagnostics Head office and Area Served
3.6 Global Key Players of Ovarian Cancer Molecular Diagnostics, Product and Application
3.7 Global Key Players of Ovarian Cancer Molecular Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Ovarian Cancer Molecular Diagnostics Breakdown Data by Type
4.1 Global Ovarian Cancer Molecular Diagnostics Historic Market Size by Type (2020-2025)
4.2 Global Ovarian Cancer Molecular Diagnostics Forecasted Market Size by Type (2026-2031)
5 Ovarian Cancer Molecular Diagnostics Breakdown Data by Application
5.1 Global Ovarian Cancer Molecular Diagnostics Historic Market Size by Application (2020-2025)
5.2 Global Ovarian Cancer Molecular Diagnostics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Ovarian Cancer Molecular Diagnostics Market Size (2020-2031)
6.2 North America Ovarian Cancer Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Ovarian Cancer Molecular Diagnostics Market Size by Country (2020-2025)
6.4 North America Ovarian Cancer Molecular Diagnostics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Ovarian Cancer Molecular Diagnostics Market Size (2020-2031)
7.2 Europe Ovarian Cancer Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Ovarian Cancer Molecular Diagnostics Market Size by Country (2020-2025)
7.4 Europe Ovarian Cancer Molecular Diagnostics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Ovarian Cancer Molecular Diagnostics Market Size (2020-2031)
8.2 Asia-Pacific Ovarian Cancer Molecular Diagnostics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Ovarian Cancer Molecular Diagnostics Market Size by Region (2020-2025)
8.4 Asia-Pacific Ovarian Cancer Molecular Diagnostics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Ovarian Cancer Molecular Diagnostics Market Size (2020-2031)
9.2 Latin America Ovarian Cancer Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Ovarian Cancer Molecular Diagnostics Market Size by Country (2020-2025)
9.4 Latin America Ovarian Cancer Molecular Diagnostics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Ovarian Cancer Molecular Diagnostics Market Size (2020-2031)
10.2 Middle East & Africa Ovarian Cancer Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Ovarian Cancer Molecular Diagnostics Market Size by Country (2020-2025)
10.4 Middle East & Africa Ovarian Cancer Molecular Diagnostics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Ovarian Cancer Molecular Diagnostics Introduction
11.1.4 Roche Revenue in Ovarian Cancer Molecular Diagnostics Business (2020-2025)
11.1.5 Roche Recent Development
11.2 Foundationmedicine
11.2.1 Foundationmedicine Company Details
11.2.2 Foundationmedicine Business Overview
11.2.3 Foundationmedicine Ovarian Cancer Molecular Diagnostics Introduction
11.2.4 Foundationmedicine Revenue in Ovarian Cancer Molecular Diagnostics Business (2020-2025)
11.2.5 Foundationmedicine Recent Development
11.3 Tellgen
11.3.1 Tellgen Company Details
11.3.2 Tellgen Business Overview
11.3.3 Tellgen Ovarian Cancer Molecular Diagnostics Introduction
11.3.4 Tellgen Revenue in Ovarian Cancer Molecular Diagnostics Business (2020-2025)
11.3.5 Tellgen Recent Development
11.4 Sansure
11.4.1 Sansure Company Details
11.4.2 Sansure Business Overview
11.4.3 Sansure Ovarian Cancer Molecular Diagnostics Introduction
11.4.4 Sansure Revenue in Ovarian Cancer Molecular Diagnostics Business (2020-2025)
11.4.5 Sansure Recent Development
11.5 Premed
11.5.1 Premed Company Details
11.5.2 Premed Business Overview
11.5.3 Premed Ovarian Cancer Molecular Diagnostics Introduction
11.5.4 Premed Revenue in Ovarian Cancer Molecular Diagnostics Business (2020-2025)
11.5.5 Premed Recent Development
11.6 Berryoncology
11.6.1 Berryoncology Company Details
11.6.2 Berryoncology Business Overview
11.6.3 Berryoncology Ovarian Cancer Molecular Diagnostics Introduction
11.6.4 Berryoncology Revenue in Ovarian Cancer Molecular Diagnostics Business (2020-2025)
11.6.5 Berryoncology Recent Development
11.7 Helixgen
11.7.1 Helixgen Company Details
11.7.2 Helixgen Business Overview
11.7.3 Helixgen Ovarian Cancer Molecular Diagnostics Introduction
11.7.4 Helixgen Revenue in Ovarian Cancer Molecular Diagnostics Business (2020-2025)
11.7.5 Helixgen Recent Development
11.8 Annoroad
11.8.1 Annoroad Company Details
11.8.2 Annoroad Business Overview
11.8.3 Annoroad Ovarian Cancer Molecular Diagnostics Introduction
11.8.4 Annoroad Revenue in Ovarian Cancer Molecular Diagnostics Business (2020-2025)
11.8.5 Annoroad Recent Development
11.9 Topgen
11.9.1 Topgen Company Details
11.9.2 Topgen Business Overview
11.9.3 Topgen Ovarian Cancer Molecular Diagnostics Introduction
11.9.4 Topgen Revenue in Ovarian Cancer Molecular Diagnostics Business (2020-2025)
11.9.5 Topgen Recent Development
11.10 Geneis
11.10.1 Geneis Company Details
11.10.2 Geneis Business Overview
11.10.3 Geneis Ovarian Cancer Molecular Diagnostics Introduction
11.10.4 Geneis Revenue in Ovarian Cancer Molecular Diagnostics Business (2020-2025)
11.10.5 Geneis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Ovarian Cancer Molecular Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of PCR
Table 3. Key Players of FISH
Table 4. Key Players of DNA Sequencing
Table 5. Key Players of Gene Chip
Table 6. Global Ovarian Cancer Molecular Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Ovarian Cancer Molecular Diagnostics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Ovarian Cancer Molecular Diagnostics Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Ovarian Cancer Molecular Diagnostics Market Share by Region (2020-2025)
Table 10. Global Ovarian Cancer Molecular Diagnostics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Ovarian Cancer Molecular Diagnostics Market Share by Region (2026-2031)
Table 12. Ovarian Cancer Molecular Diagnostics Market Trends
Table 13. Ovarian Cancer Molecular Diagnostics Market Drivers
Table 14. Ovarian Cancer Molecular Diagnostics Market Challenges
Table 15. Ovarian Cancer Molecular Diagnostics Market Restraints
Table 16. Global Ovarian Cancer Molecular Diagnostics Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Ovarian Cancer Molecular Diagnostics Market Share by Players (2020-2025)
Table 18. Global Top Ovarian Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ovarian Cancer Molecular Diagnostics as of 2024)
Table 19. Ranking of Global Top Ovarian Cancer Molecular Diagnostics Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Ovarian Cancer Molecular Diagnostics Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Ovarian Cancer Molecular Diagnostics, Headquarters and Area Served
Table 22. Global Key Players of Ovarian Cancer Molecular Diagnostics, Product and Application
Table 23. Global Key Players of Ovarian Cancer Molecular Diagnostics, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Ovarian Cancer Molecular Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Ovarian Cancer Molecular Diagnostics Revenue Market Share by Type (2020-2025)
Table 27. Global Ovarian Cancer Molecular Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Ovarian Cancer Molecular Diagnostics Revenue Market Share by Type (2026-2031)
Table 29. Global Ovarian Cancer Molecular Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Ovarian Cancer Molecular Diagnostics Revenue Market Share by Application (2020-2025)
Table 31. Global Ovarian Cancer Molecular Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Ovarian Cancer Molecular Diagnostics Revenue Market Share by Application (2026-2031)
Table 33. North America Ovarian Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Ovarian Cancer Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Ovarian Cancer Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Ovarian Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Ovarian Cancer Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Ovarian Cancer Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Ovarian Cancer Molecular Diagnostics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Ovarian Cancer Molecular Diagnostics Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Ovarian Cancer Molecular Diagnostics Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Ovarian Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Ovarian Cancer Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Ovarian Cancer Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Ovarian Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Ovarian Cancer Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Ovarian Cancer Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 48. Roche Company Details
Table 49. Roche Business Overview
Table 50. Roche Ovarian Cancer Molecular Diagnostics Product
Table 51. Roche Revenue in Ovarian Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 52. Roche Recent Development
Table 53. Foundationmedicine Company Details
Table 54. Foundationmedicine Business Overview
Table 55. Foundationmedicine Ovarian Cancer Molecular Diagnostics Product
Table 56. Foundationmedicine Revenue in Ovarian Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 57. Foundationmedicine Recent Development
Table 58. Tellgen Company Details
Table 59. Tellgen Business Overview
Table 60. Tellgen Ovarian Cancer Molecular Diagnostics Product
Table 61. Tellgen Revenue in Ovarian Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 62. Tellgen Recent Development
Table 63. Sansure Company Details
Table 64. Sansure Business Overview
Table 65. Sansure Ovarian Cancer Molecular Diagnostics Product
Table 66. Sansure Revenue in Ovarian Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 67. Sansure Recent Development
Table 68. Premed Company Details
Table 69. Premed Business Overview
Table 70. Premed Ovarian Cancer Molecular Diagnostics Product
Table 71. Premed Revenue in Ovarian Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 72. Premed Recent Development
Table 73. Berryoncology Company Details
Table 74. Berryoncology Business Overview
Table 75. Berryoncology Ovarian Cancer Molecular Diagnostics Product
Table 76. Berryoncology Revenue in Ovarian Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 77. Berryoncology Recent Development
Table 78. Helixgen Company Details
Table 79. Helixgen Business Overview
Table 80. Helixgen Ovarian Cancer Molecular Diagnostics Product
Table 81. Helixgen Revenue in Ovarian Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 82. Helixgen Recent Development
Table 83. Annoroad Company Details
Table 84. Annoroad Business Overview
Table 85. Annoroad Ovarian Cancer Molecular Diagnostics Product
Table 86. Annoroad Revenue in Ovarian Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 87. Annoroad Recent Development
Table 88. Topgen Company Details
Table 89. Topgen Business Overview
Table 90. Topgen Ovarian Cancer Molecular Diagnostics Product
Table 91. Topgen Revenue in Ovarian Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 92. Topgen Recent Development
Table 93. Geneis Company Details
Table 94. Geneis Business Overview
Table 95. Geneis Ovarian Cancer Molecular Diagnostics Product
Table 96. Geneis Revenue in Ovarian Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 97. Geneis Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 101. Authors List of This Report
List of Figures
Figure 1. Ovarian Cancer Molecular Diagnostics Picture
Figure 2. Global Ovarian Cancer Molecular Diagnostics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Ovarian Cancer Molecular Diagnostics Market Share by Type: 2024 VS 2031
Figure 4. PCR Features
Figure 5. FISH Features
Figure 6. DNA Sequencing Features
Figure 7. Gene Chip Features
Figure 8. Global Ovarian Cancer Molecular Diagnostics Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Ovarian Cancer Molecular Diagnostics Market Share by Application: 2024 VS 2031
Figure 10. Clinical Diagnosis Case Studies
Figure 11. Drug Screening Case Studies
Figure 12. Research Case Studies
Figure 13. Ovarian Cancer Molecular Diagnostics Report Years Considered
Figure 14. Global Ovarian Cancer Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Ovarian Cancer Molecular Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Ovarian Cancer Molecular Diagnostics Market Share by Region: 2024 VS 2031
Figure 17. Global Ovarian Cancer Molecular Diagnostics Market Share by Players in 2024
Figure 18. Global Top Ovarian Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ovarian Cancer Molecular Diagnostics as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Ovarian Cancer Molecular Diagnostics Revenue in 2024
Figure 20. North America Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Ovarian Cancer Molecular Diagnostics Market Share by Country (2020-2031)
Figure 22. United States Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Ovarian Cancer Molecular Diagnostics Market Share by Country (2020-2031)
Figure 26. Germany Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Ovarian Cancer Molecular Diagnostics Market Share by Region (2020-2031)
Figure 34. China Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Ovarian Cancer Molecular Diagnostics Market Share by Country (2020-2031)
Figure 42. Mexico Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Ovarian Cancer Molecular Diagnostics Market Share by Country (2020-2031)
Figure 46. Turkey Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Roche Revenue Growth Rate in Ovarian Cancer Molecular Diagnostics Business (2020-2025)
Figure 50. Foundationmedicine Revenue Growth Rate in Ovarian Cancer Molecular Diagnostics Business (2020-2025)
Figure 51. Tellgen Revenue Growth Rate in Ovarian Cancer Molecular Diagnostics Business (2020-2025)
Figure 52. Sansure Revenue Growth Rate in Ovarian Cancer Molecular Diagnostics Business (2020-2025)
Figure 53. Premed Revenue Growth Rate in Ovarian Cancer Molecular Diagnostics Business (2020-2025)
Figure 54. Berryoncology Revenue Growth Rate in Ovarian Cancer Molecular Diagnostics Business (2020-2025)
Figure 55. Helixgen Revenue Growth Rate in Ovarian Cancer Molecular Diagnostics Business (2020-2025)
Figure 56. Annoroad Revenue Growth Rate in Ovarian Cancer Molecular Diagnostics Business (2020-2025)
Figure 57. Topgen Revenue Growth Rate in Ovarian Cancer Molecular Diagnostics Business (2020-2025)
Figure 58. Geneis Revenue Growth Rate in Ovarian Cancer Molecular Diagnostics Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global Ovarian Cancer Molecular Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of PCR
Table 3. Key Players of FISH
Table 4. Key Players of DNA Sequencing
Table 5. Key Players of Gene Chip
Table 6. Global Ovarian Cancer Molecular Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Ovarian Cancer Molecular Diagnostics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Ovarian Cancer Molecular Diagnostics Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Ovarian Cancer Molecular Diagnostics Market Share by Region (2020-2025)
Table 10. Global Ovarian Cancer Molecular Diagnostics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Ovarian Cancer Molecular Diagnostics Market Share by Region (2026-2031)
Table 12. Ovarian Cancer Molecular Diagnostics Market Trends
Table 13. Ovarian Cancer Molecular Diagnostics Market Drivers
Table 14. Ovarian Cancer Molecular Diagnostics Market Challenges
Table 15. Ovarian Cancer Molecular Diagnostics Market Restraints
Table 16. Global Ovarian Cancer Molecular Diagnostics Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Ovarian Cancer Molecular Diagnostics Market Share by Players (2020-2025)
Table 18. Global Top Ovarian Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ovarian Cancer Molecular Diagnostics as of 2024)
Table 19. Ranking of Global Top Ovarian Cancer Molecular Diagnostics Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Ovarian Cancer Molecular Diagnostics Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Ovarian Cancer Molecular Diagnostics, Headquarters and Area Served
Table 22. Global Key Players of Ovarian Cancer Molecular Diagnostics, Product and Application
Table 23. Global Key Players of Ovarian Cancer Molecular Diagnostics, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Ovarian Cancer Molecular Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Ovarian Cancer Molecular Diagnostics Revenue Market Share by Type (2020-2025)
Table 27. Global Ovarian Cancer Molecular Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Ovarian Cancer Molecular Diagnostics Revenue Market Share by Type (2026-2031)
Table 29. Global Ovarian Cancer Molecular Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Ovarian Cancer Molecular Diagnostics Revenue Market Share by Application (2020-2025)
Table 31. Global Ovarian Cancer Molecular Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Ovarian Cancer Molecular Diagnostics Revenue Market Share by Application (2026-2031)
Table 33. North America Ovarian Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Ovarian Cancer Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Ovarian Cancer Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Ovarian Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Ovarian Cancer Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Ovarian Cancer Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Ovarian Cancer Molecular Diagnostics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Ovarian Cancer Molecular Diagnostics Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Ovarian Cancer Molecular Diagnostics Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Ovarian Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Ovarian Cancer Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Ovarian Cancer Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Ovarian Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Ovarian Cancer Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Ovarian Cancer Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 48. Roche Company Details
Table 49. Roche Business Overview
Table 50. Roche Ovarian Cancer Molecular Diagnostics Product
Table 51. Roche Revenue in Ovarian Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 52. Roche Recent Development
Table 53. Foundationmedicine Company Details
Table 54. Foundationmedicine Business Overview
Table 55. Foundationmedicine Ovarian Cancer Molecular Diagnostics Product
Table 56. Foundationmedicine Revenue in Ovarian Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 57. Foundationmedicine Recent Development
Table 58. Tellgen Company Details
Table 59. Tellgen Business Overview
Table 60. Tellgen Ovarian Cancer Molecular Diagnostics Product
Table 61. Tellgen Revenue in Ovarian Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 62. Tellgen Recent Development
Table 63. Sansure Company Details
Table 64. Sansure Business Overview
Table 65. Sansure Ovarian Cancer Molecular Diagnostics Product
Table 66. Sansure Revenue in Ovarian Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 67. Sansure Recent Development
Table 68. Premed Company Details
Table 69. Premed Business Overview
Table 70. Premed Ovarian Cancer Molecular Diagnostics Product
Table 71. Premed Revenue in Ovarian Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 72. Premed Recent Development
Table 73. Berryoncology Company Details
Table 74. Berryoncology Business Overview
Table 75. Berryoncology Ovarian Cancer Molecular Diagnostics Product
Table 76. Berryoncology Revenue in Ovarian Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 77. Berryoncology Recent Development
Table 78. Helixgen Company Details
Table 79. Helixgen Business Overview
Table 80. Helixgen Ovarian Cancer Molecular Diagnostics Product
Table 81. Helixgen Revenue in Ovarian Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 82. Helixgen Recent Development
Table 83. Annoroad Company Details
Table 84. Annoroad Business Overview
Table 85. Annoroad Ovarian Cancer Molecular Diagnostics Product
Table 86. Annoroad Revenue in Ovarian Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 87. Annoroad Recent Development
Table 88. Topgen Company Details
Table 89. Topgen Business Overview
Table 90. Topgen Ovarian Cancer Molecular Diagnostics Product
Table 91. Topgen Revenue in Ovarian Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 92. Topgen Recent Development
Table 93. Geneis Company Details
Table 94. Geneis Business Overview
Table 95. Geneis Ovarian Cancer Molecular Diagnostics Product
Table 96. Geneis Revenue in Ovarian Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 97. Geneis Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 101. Authors List of This Report
List of Figures
Figure 1. Ovarian Cancer Molecular Diagnostics Picture
Figure 2. Global Ovarian Cancer Molecular Diagnostics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Ovarian Cancer Molecular Diagnostics Market Share by Type: 2024 VS 2031
Figure 4. PCR Features
Figure 5. FISH Features
Figure 6. DNA Sequencing Features
Figure 7. Gene Chip Features
Figure 8. Global Ovarian Cancer Molecular Diagnostics Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Ovarian Cancer Molecular Diagnostics Market Share by Application: 2024 VS 2031
Figure 10. Clinical Diagnosis Case Studies
Figure 11. Drug Screening Case Studies
Figure 12. Research Case Studies
Figure 13. Ovarian Cancer Molecular Diagnostics Report Years Considered
Figure 14. Global Ovarian Cancer Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Ovarian Cancer Molecular Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Ovarian Cancer Molecular Diagnostics Market Share by Region: 2024 VS 2031
Figure 17. Global Ovarian Cancer Molecular Diagnostics Market Share by Players in 2024
Figure 18. Global Top Ovarian Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ovarian Cancer Molecular Diagnostics as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Ovarian Cancer Molecular Diagnostics Revenue in 2024
Figure 20. North America Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Ovarian Cancer Molecular Diagnostics Market Share by Country (2020-2031)
Figure 22. United States Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Ovarian Cancer Molecular Diagnostics Market Share by Country (2020-2031)
Figure 26. Germany Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Ovarian Cancer Molecular Diagnostics Market Share by Region (2020-2031)
Figure 34. China Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Ovarian Cancer Molecular Diagnostics Market Share by Country (2020-2031)
Figure 42. Mexico Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Ovarian Cancer Molecular Diagnostics Market Share by Country (2020-2031)
Figure 46. Turkey Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Ovarian Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Roche Revenue Growth Rate in Ovarian Cancer Molecular Diagnostics Business (2020-2025)
Figure 50. Foundationmedicine Revenue Growth Rate in Ovarian Cancer Molecular Diagnostics Business (2020-2025)
Figure 51. Tellgen Revenue Growth Rate in Ovarian Cancer Molecular Diagnostics Business (2020-2025)
Figure 52. Sansure Revenue Growth Rate in Ovarian Cancer Molecular Diagnostics Business (2020-2025)
Figure 53. Premed Revenue Growth Rate in Ovarian Cancer Molecular Diagnostics Business (2020-2025)
Figure 54. Berryoncology Revenue Growth Rate in Ovarian Cancer Molecular Diagnostics Business (2020-2025)
Figure 55. Helixgen Revenue Growth Rate in Ovarian Cancer Molecular Diagnostics Business (2020-2025)
Figure 56. Annoroad Revenue Growth Rate in Ovarian Cancer Molecular Diagnostics Business (2020-2025)
Figure 57. Topgen Revenue Growth Rate in Ovarian Cancer Molecular Diagnostics Business (2020-2025)
Figure 58. Geneis Revenue Growth Rate in Ovarian Cancer Molecular Diagnostics Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Household Embroidery Machines Market Research Report 2025
Jul 18, 25
Global Residential Electric Underfloor Heating Market Research Report 2025
Jul 18, 25
Global Commercial Electric Underfloor Heating Market Research Report 2025
Jul 18, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232